639. MicroRNA-Mediated Multi-Tissue-Detargeting of Oncolytic Measles Virus

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)34974-7
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

Specific Elimination of CD133+ Tumor Cells With Targeted Oncolytic Measles Virus

Cancer Research
Cancer ResearchOncology
2013English

642. Pre-Existing Antiviral State Can Impact Oncolytic Infection in Glioblastoma Patients Treated With Oncolytic Measles Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2014English

High CD46 Receptor Density Determines Preferential Killing of Tumor Cells by Oncolytic Measles Virus

Cancer Research
Cancer ResearchOncology
2004English

Adaptation of Wild-Type Measles Virus to Tissue Culture

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2002English

Potential and Clinical Translation of Oncolytic Measles Viruses

Expert Opinion on Biological Therapy
Drug DiscoveryClinical BiochemistryPharmacology
2017English

639. Oncolytic Adenovirus Expressing IFN Alpha Works Synergistically With Chemoradiation

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Tumor and Vascular Targeting of a Novel Oncolytic Measles Virus Retargeted Against the Urokinase Receptor

Cancer Research
Cancer ResearchOncology
2009English

Measles Virus Selectively Blind to Signaling Lymphocyte Activation Molecule as a Novel Oncolytic Virus for Breast Cancer Treatment

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2012English

Expression of Immunomodulatory Neutrophil-Activating Protein of Helicobacter Pylori Enhances the Antitumor Activity of Oncolytic Measles Virus

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy